Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

Detalles Bibliográficos
Autores principales: Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Brauer, Dominic, Backhaus, Donata, Schulz, Julia, Goldmann, Karoline, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084997/
https://www.ncbi.nlm.nih.gov/pubmed/33927190
http://dx.doi.org/10.1038/s41408-021-00471-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084997/
https://www.ncbi.nlm.nih.gov/pubmed/33927190
http://dx.doi.org/10.1038/s41408-021-00471-x

Ejemplares similares